Endovascular repair of iliac artery aneurysms is an emerging alternative to open surgical repair. One challenge with endovascular aneurysm repair (EVAR) is the preservation of hypogastric artery perfusion. Complications from bilateral hypogastric occlusion may be significant (buttock claudication and erectile dysfunction) or even devastating (pelvic ischemia, colon ischemia, paralysis). 1 The GORE EXCLUDER Iliac Branch Endoprosthesis (IBE; W. L. Gore and Associates, Flagstaff, Ariz) received United States Food and Drug Administration approval in March 2016 for endovascular treatment of common iliac aneurysms as an adjunct to EVAR, offering a solution to preserve hypogastric perfusion. The device is a bifurcated stent graft with one branch extending into the hypogastric artery and one branch extending into the external iliac artery. We present an off-label application of the GORE EXCLUDER IBE to treat an isolated internal iliac artery aneurysm (IIIAA) as part of a two-staged repair of bilateral IIIAAs, one of which was ruptured during the initial presentation. The patient was informed and consented to the writing of this report.
CASE REPORT
Initial presentation. A 70-year-old man presented to the emergency department with sudden right flank and groin pain, tachycardia, and tenderness along right lower quadrant and buttock. His medical history included hypertension, hyperlipidemia, nephrolithiasis, erectile dysfunction, and prior smoking. A computed tomography scan demonstrated a ruptured 5-cm right hypogastric artery aneurysm, free fluid in the pelvis, a 3.5-cm left hypogastric artery aneurysm, and a normal aorta and common iliac arteries (Fig 1) .
EVAR of ruptured right hypogastric aneurysm. The anterior and posterior divisions of the hypogastric artery were cannulated and embolized using a microcatheter system. The main hypogastric artery was then embolized back to the iliac bifurcation. A GORE EXCLUDER iliac limb was used to cover the origin of the hypogastric artery and exclude the ruptured aneurysm (Fig 1) . The patient was discharged without symptoms. instructions for use (IFU) specify a minimum of 10 mm of overlap is required at the distal and proximal landing zones. 2 The patient's common iliac artery was >55 mm long, allowing for deployment of the device within the iliac vessels and not compromising the aortic bifurcation. The left common iliac diameter was 14 mm at the origin and 16 mm at the bifurcation.
The distal gluteal artery was 8 mm in diameter. We chose the gluteal artery as a landing zone because it had an adequate diameter, enough length for at least a 10-mm landing zone, lacked tortuosity, and addressed the patient's primary concern The stents were deployed in a proximal-to-distal manner because there was no size discrepancy.
A completion angiogram demonstrated successful exclusion of the aneurysm with perfusion maintained to the gluteal artery (Fig 2) . The patient was discharged home on postoperative day 1.
At 1 month after the repair, he was asymptomatic. A computed tomography angiogram (Fig 3) showed aneurysm exclusion and patent gluteal artery.
DISCUSSION
Isolated iliac artery aneurysms are present in w0.03% of general population. IIIAA are even rarer, comprising <30% of all isolated iliac aneurysms. 3 Multiple studies define the natural history of abdominal aortic aneurysms and the indications for repair. 5, 6 The lower prevalence of IIIAAs precludes such studies. Typically, intervention is warranted on IIIAAs in the case of rupture, symptoms, rapid growth, and asymptomatic aneurysms >3 cm. 7 Approximately half of iliac artery aneurysms are symptomatic at first presentation 8 and produce symptoms through compression of the colon, ureter, and lumbar plexus. 7 Rarely, common and external iliac aneurysms can present with lower extremity ischemia. 9 Approximately 31% to 40% of all IIIAAs present are already ruptured. 3, 4 In the review by Wilhelm et al, 4 the average diameter of IIIAAs was 7.4 cm, and the overall mortality was 21.8%. The average diameter was 5.1 cm among asymptomatic aneurysms, 7.6 cm among symptomatic aneurysms, and >8 cm among free ruptures, and mortality was 0%, 21.8%, and 52.9%, respectively. Dix et al 3 reported a similar mortality rate among ruptured IIIAAs. Management of IIIAAs includes ligation, endoaneurysmorrhaphy, arterial reconstruction, and embolization, with or without stent grafting. 4 More recently, endovascular repairs, such as bell-bottom iliac limbs, crosschimney, and double-barrel technique, have been described. Embolization has been associated with significant buttock claudication rates of 38%.
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In the United States pivotal trial of the IBE and Global Registry for Endovascular Aortic Treatment (GREAT), 121 patients were treated for common iliac aneurysms with IBE during EVAR repair of abdominal aortic aneurysms. These registries confirm that IBE is safe and effective in aortoiliac and common iliac artery aneurysms. 11 However, we used the IBE device for the repair of IIIAA in our patient, who did not have aortic or common iliac artery pathology; the procedure was technically feasible and safe. The 30-day follow-up showed successful aneurysm exclusion and gluteal perfusion without endoleak. In our patient, the emergency treatment of the ruptured right IIIAA did not allow for hypogastric preservation. Therefore, when treating the left IIIAA, preserving hypogastric inflow was of paramount importance. Previously described endovascular techniques to preserve pelvic perfusion, including cross-chimney and double-barrel technique, were considered; however, we felt that the probability of limb kinking, occlusion or "gutter leak" was significant. 12, 13 The use of the GORE EXCLUDER IBE is outside the IFU and may be associated with an increased risk of secondary and other adverse events. 14 However, in a recent report from our group of outcomes in 566 patients, no statistical difference was found in adverse events for patients treated with EVAR outside the IFU. 15 Nevertheless, the long-term durability of our intervention will require close monitoring with clinical evaluation and imaging.
CONCLUSIONS
The GORE EXCLUDER IBE proved valuable in the treatment of IIIAAs, even in the absence of aortic pathology. Although further studies are required to demonstrate the durability of the GORE EXCLUDER IBE, the device widened our endovascular therapeutic options when the importance of preserved hypogastric perfusion is increasingly evident.
